Drug-labels.com

Cefprozil Powder for Oral Suspension: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Current status: Cancelled Pre Market Facts
Strength:
250 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - Cefprozil Powder for Oral Suspension

ABOUT THIS MEDICATION

What the medication is used for:

CEFPROZIL Powder for Oral Suspension is used for the treatment of infections caused by bacteria (germs) such as bronchitis and infections of the ears, sinuses, skin, throat and urinary tract.

Antibacterial drugs like CEFPROZIL Powder for Oral Suspension treat only bacterial infections. They do not treat viral infections such as the common cold. Although you may feel better early in treatment, CEFPROZIL Powder for Oral Suspension should be used exactly as directed. Misuse or overuse of CEFPROZIL Powder for Oral Suspension could lead to the growth of bacteria that will not be killed by CEFPROZIL Powder for Oral Suspension (resistance).

This means that CEFPROZIL Powder for Oral Suspension may not work for you in the future. Do not share your medicine.

What it does:

CEFPORZIL Powder for Oral Suspension kills the bacteria that cause infections.

When it should not be used:

Do not use if allergic to cefprozil or any of the non-medicinal ingredients present in CEFPROZIL Powder for Oral Suspension (See “What the important non-medicinal ingredients are” section below).

What the medicinal ingredient is:

cefprozil as cefprozil monohydrate

What the important nonmedicinal ingredients are:

CEFPROZIL Powder for Oral Suspension: aspartame, citric acid anhydrous, colloidal silicon dioxide, FD&C Red # 40 aluminium lake, FD&C yellow # 6 aluminium lake, flavor fruit gum 912, flavor cherry 594 SD, glycine, polysorbate 80, simethicone emulsion, sodium benzoate, sodium chloride, microcrystalline cellulose & carboxymethylcellulose sodium, carboxymethyl cellulose sodium and sucrose.

What dosage forms it comes in:

Powder for Oral Suspension (250 mg/5mL when reconstituted).

WARNINGS AND PRECAUTIONS

Before starting CEFPROZIL Powder for Oral Suspension and to get the best possible treatment, be sure to tell your doctor if you:

  • Are allergic to penicillins, cephalopsporins, cefprozil or any other drugs.
  • Are pregnant, plan to become pregnant or are breastfeeding.

Do not use for children below the age of 6 months.

Caution is required when cefprozil is used for the chronically ill or institutionalized elderly.

INTERACTIONS WITH THIS MEDICATION

Drugs that may interact with CEFPROZIL Powder for Oral Suspension include: aminoglycoside antibiotics, probenecid.

Before you use CEFPROZIL talk to your doctor or pharmacist.

TERACTIONS WITH THIS MEDICATION

PROPER USE OF THIS MEDICATION

Usual dose:

You must take this medication as told by your doctor. The usual dose depends on your age, weight and the type of infection that you have. The maximum daily dose for infants and children (6 months to 12 years of age) should not exceed the maximum daily dose recommended for adults which is 1 g per day.

It is important that you take all the medicine that your doctor has given you. Even if you start to feel better, all the medicine must be taken to make sure that all the germs have been killed.

CEFPROZIL Powder for Oral Suspension may be taken with or without food.

Shake the reconstituted suspension well before use.

Overdose:

Call your doctor or pharmacist right away in case of an overdose.

Missed Dose: Call your doctor or pharmacist right away in case of a missed dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effects are diarrhea, nausea, vomiting and abdominal pain.

This is not a complete list of side effects. For any unexpected effects while taking CEFPROZIL Powder for Oral Suspension, contact your doctor or pharmacist.

HOW TO STORE IT

Remember to keep CEFPROZIL well out of reach of children.

Store the dry powder at room temperature (15° to 30°C). Protect from light and excessive humidity.

Store the reconstituted CEFPROZIL Oral Suspension in the refrigerator (2°C - 8°C) for up to 14 days. Keep container tightly closed. Throw out the remaining suspension after 14 days.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health- canada/services/drugs-health- products/medeffect-canada/adverse-reaction- reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about CEFPROZIL:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this patient medication information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html) or by calling 1.866.840.1340.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02332027

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Cefprozil Powder for Oral Suspension

Rx or OTC
Prescription (Rx)?
DIN 02332027
Schedule(s) PRESCRIPTION
Active ingredient(s) Cefprozil (cefprozil monohydrate) 250 MG
Dosage form(s) Powder For Suspension
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01D Other beta-lactam antibacterials
        1. J01DC Second-generation cephalosporins
          1. J01DC10 Cefprozil
Company RANBAXY PHARMACEUTICALS CANADA INC.
Current status Cancelled Pre Market
Current status date July 10, 2025

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.